Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Fosfomycin-resistant Escherichia coli: a FosA10 case in Italy

V. Mattioni Marchetti, I. Petrizzi, I. Venturelli, T. Cassetti, M. Meschiari, R. Migliavacca, I. Bitar

. 2025 ; 7 (2) : dlaf052. [pub] 20250409

Status not-indexed Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25014582

BACKGROUND: FosA10-producing Enterobacterales have an extremely low incidence in Europe. PATIENTS AND METHODS: In March 2024, an 83-year-old woman, hospitalized in the Modena Province, developed an infection with fosfomycin-resistant Escherichia coli. The patient was treated with piperacillin/tazobactam and, after 10 days, the clinical picture was resolved. Fosfomycin MIC was evaluated with the reference agar dilution method and the production of FosA enzymes by phenotypic testing. Genomic characterization was assessed using long-read sequencing technology on the Sequel I platform. RESULTS: An E. coli isolate (FO_2) was collected from both blood and urine samples and showed high-level resistance to fosfomycin (MIC > 128 mg/L). The resistance to fosfomycin was ascribed to the production of FosA-like enzymes by phenotypic testing. The genomic analysis pointed to a FosA10-producing E. coli ST69. The fosA10 gene was carried by a highly conjugative IncB/O/K/Z plasmid that showed relevant similarities with other globally circulating plasmids. CONCLUSIONS: The acquisition of rare fosA-like genes in clinically relevant clones is concerning and the dissemination of FosA-producing E. coli should be continuously monitored.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25014582
003      
CZ-PrNML
005      
20250905141503.0
007      
ta
008      
250701s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/jacamr/dlaf052 $2 doi
035    __
$a (PubMed)40206832
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Mattioni Marchetti, Vittoria $u S.C.C.D.P. Department, Microbiology and Clinical Microbiology Unit, University of Pavia, Pavia, Italy $1 https://orcid.org/000000032786846X
245    10
$a Fosfomycin-resistant Escherichia coli: a FosA10 case in Italy / $c V. Mattioni Marchetti, I. Petrizzi, I. Venturelli, T. Cassetti, M. Meschiari, R. Migliavacca, I. Bitar
520    9_
$a BACKGROUND: FosA10-producing Enterobacterales have an extremely low incidence in Europe. PATIENTS AND METHODS: In March 2024, an 83-year-old woman, hospitalized in the Modena Province, developed an infection with fosfomycin-resistant Escherichia coli. The patient was treated with piperacillin/tazobactam and, after 10 days, the clinical picture was resolved. Fosfomycin MIC was evaluated with the reference agar dilution method and the production of FosA enzymes by phenotypic testing. Genomic characterization was assessed using long-read sequencing technology on the Sequel I platform. RESULTS: An E. coli isolate (FO_2) was collected from both blood and urine samples and showed high-level resistance to fosfomycin (MIC > 128 mg/L). The resistance to fosfomycin was ascribed to the production of FosA-like enzymes by phenotypic testing. The genomic analysis pointed to a FosA10-producing E. coli ST69. The fosA10 gene was carried by a highly conjugative IncB/O/K/Z plasmid that showed relevant similarities with other globally circulating plasmids. CONCLUSIONS: The acquisition of rare fosA-like genes in clinically relevant clones is concerning and the dissemination of FosA-producing E. coli should be continuously monitored.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Petrizzi, Ilaria $u S.C.C.D.P. Department, Microbiology and Clinical Microbiology Unit, University of Pavia, Pavia, Italy
700    1_
$a Venturelli, Irene $u Clinical Microbiology, AUSL Modena, 41125 Modena, Italy
700    1_
$a Cassetti, Tiziana $u Clinical Microbiology, AUSL Modena, 41125 Modena, Italy
700    1_
$a Meschiari, Marianna $u Infectious Diseases Clinic, AOU Policlinico di Modena, Modena, Italy
700    1_
$a Migliavacca, Roberta $u S.C.C.D.P. Department, Microbiology and Clinical Microbiology Unit, University of Pavia, Pavia, Italy $u I.R.C.C.S. Policlinico S. Matteo, SC Microbiology and Virology, Department of Diagnostic and Laboratory Medicine, Pavia, Italy
700    1_
$a Bitar, Ibrahim $u Department of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia $u Biomedical Center, Faculty of Medicine, Charles University, Pilsen, Czechia $1 https://orcid.org/0000000291173729
773    0_
$w MED00214252 $t JAC-antimicrobial resistance $x 2632-1823 $g Roč. 7, č. 2 (2025), s. dlaf052
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40206832 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250701 $b ABA008
991    __
$a 20250905141450 $b ABA008
999    __
$a ok $b bmc $g 2388127 $s 1251702
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 7 $c 2 $d dlaf052 $e 20250409 $i 2632-1823 $m JAC-antimicrobial resistance $n JAC Antimicrob Resist $x MED00214252
LZP    __
$a Pubmed-20250701

Find record

Citation metrics

Archiving options